Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy-Reference-Cited by-同舟云学术

Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy

Published:2019-05-16 Issue:6 Volume:18 Page:2666-2675
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Murphy J. Patrick,Kim Youra,Clements Derek R.,Konda Prathyusha,Schuster Heiko¹²,Kowalewski Daniel J.¹²,Paulo Joao A.³,Cohen Alejandro M.,Stevanovic Stefan¹,Gygi Steven P.³,Gujar Shashi^ORCID

Affiliation:

1. Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, 72074 Tübingen, Germany

2. Immatics Biotechnologies GmbH, 72076 Tübingen, Germany

3. Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States

Funder

Canadian Institutes of Health Research

National Institute of Diabetes and Digestive and Kidney Diseases

Dalhousie Medical Research Foundation

Canadian Cancer Society Research Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.9b00173

Reference46 articles.

1. Cancer immunotherapy

2. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

3. Immunogenic cell death in cancer and infectious disease

4. Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment

5. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

2. Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies;Cancer Immunology Research;2024-01-09

3. Emerging reoviruses: the next pandemic?;Virologie;2023-06

4. Emerging reoviruses: the next pandemic?;Virologie;2023-06

5. Integrating immunopeptidome analysis for the design and development of cancer vaccines;Seminars in Immunology;2023-05